{"disease":{"id":"ectonucleotide-pyrophosphatase-phosphodiesterase1-deficiency","name":"ectonucleotide pyrophosphatase phosphodiesterase1 deficiency"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05734196","title":"The ENERGY Study: Evaluation of Safety and Tolerability of INZ-701 in Infants With ENPP1 Deficiency or ABCC6 Deficiency","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":16,"lead_sponsor_name":"Inozyme Pharma","has_results":false},{"nct_id":"NCT07473973","title":"ENERGY 2: Evaluation of the Efficacy and Safety of INZ-701 in Infants With ENPP1 Deficiency","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":12,"lead_sponsor_name":"Inozyme Pharma","has_results":false},{"nct_id":"NCT05050669","title":"Natural History Study of ENPP1 Deficiency and the Early-onset Form of ABCC6 Deficiency","phase":"","overall_status":"COMPLETED","enrollment_count":12,"lead_sponsor_name":"Inozyme Pharma","has_results":false},{"nct_id":"NCT04686175","title":"Evaluation of Safety, Tolerability, and Efficacy of INZ-701 in Adults With ENPP1 Deficiency","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":9,"lead_sponsor_name":"Inozyme Pharma","has_results":false},{"nct_id":"NCT06739980","title":"The ENABLE Study: Safety and Efficacy Study of INZ-701 in Patients With ENPP1 Deficiency","phase":"PHASE2","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Inozyme Pharma","has_results":false}],"total":5},"guidelines":[],"source":"Drug Landscape verified database"}